ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION

被引：6
|
作者：
Beigel, J. H. [1 ]
机构：
[1] NCI, Immunoregulat Lab, Div Intramural Res, NIAID,SAIC Frederick Inc,NIH, Frederick, MD 21702 USA
来源：
DRUGS OF THE FUTURE | 2010年 / 35卷 / 05期
基金：
美国国家卫生研究院;
关键词：
CYCLOPENTANE NEURAMINIDASE INHIBITORS; IN-VIVO ACTIVITIES; A VIRUS-INFECTION; H5N1; VIRUS; PASSIVE IMMUNOTHERAPY; CELL-CULTURE; OSELTAMIVIR; EFFICACY; COMBINATION; ZANAMIVIR;
D O I：
10.1358/dof.2010.035.05.1487081
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The recent pandemic of H1N1 has demonstrated the potential vulnerability of the human population to novel influenza viruses. While there is recent increased interest and effort in developing effective anti-influenza agents, few new products have entered clinical studies. This review will highlight the limited armamentarium of licensed influenza agents, and discuss novel compounds and strategies that have entered clinical studies and may therefore be imminently available to the treating clinician.
引用
收藏
页码：385 / 392
页数：8
相关论文
共 50 条
  • [41] Characteristics of atopic children with pandemic H1N1 influenza viral infection: Pandemic H1N1 influenza reveals 'occult' asthma of childhood
    Hasegawa, Shunji
    Hirano, Reiji
    Hashimoto, Kunio
    Haneda, Yasuhiro
    Shirabe, Komei
    Ichiyama, Takashi
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2011, 22 (01) : e119 - e123
  • [42] Influenza A (H1N1) 2009. Review
    Mahassin, F.
    Jaureguiberry, S.
    Monsel, G.
    Caumes, E.
    Bricaire, F.
    ANTIBIOTIQUES, 2010, 12 (04): : 235 - 242
  • [43] Diagnosis and Management of Novel Influenza A (H1N1)
    Wie, Seong Heon
    Kim, Woo Joo
    KOREAN JOURNAL OF FAMILY MEDICINE, 2009, 30 (11): : 843 - 847
  • [44] Initial HRCT findings of novel influenza A (H1N1) infection
    Yuan, Ying
    Tao, Xiao-Feng
    Shi, Yu-Xin
    Liu, Shi-Yuan
    Chen, Ji-Quan
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2012, 6 (06) : e114 - e119
  • [45] Influenza A virus vaccine H1N1/influenza virus vaccineLack of efficacy in H1N1 influenza: case report
    Reactions Weekly, 2012, 1421 (1) : 31 - 31
  • [46] A case of tubulointerstitial nephritis in a patient with an influenza H1N1 infection
    Niloufar Ashtiani
    Margot F. Mulder
    Joanna A. E. van Wijk
    Arend Bokenkamp
    Pediatric Nephrology, 2012, 27 : 1985 - 1987
  • [47] Inhibition of Influenza A (H1N1) Virus Infection by Pt/TiO2-SiO2 Bionanocatalysts
    Lopez-Goerne, Tessy
    de la Rosa-Gutierrez, Gabriela
    Padilla-Godinez, Francisco J.
    Bustos-Martinez, Jaime
    Lopez, Susana
    Xoconostle-Cazares, Beatriz
    de la Rosa, Jose Manuel
    CURRENT NANOSCIENCE, 2022, 18 (06) : 733 - 742
  • [48] Exploring potential of graphene oxide as an alternative antiviral approach for influenza A H1N1
    Farsiu, Niloofar
    Mousavi, Elham
    Barani, Mahmood
    Khanbabaei, Hashem
    Ebrahimi, Saeedeh
    NANOMEDICINE, 2024, 19 (30) : 2509 - 2520
  • [49] Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase
    Wang, Ye
    Wu, Di
    Yu, Dahai
    Wang, Zhiyong
    Tian, Li
    Wang, Yanyan
    Han, Weiwei
    Fang, Xuexun
    JOURNAL OF MOLECULAR MODELING, 2012, 18 (08) : 3445 - 3453
  • [50] Peramivir: An Intravenous Neuraminidase Inhibitor for the Treatment of 2009 H1N1 Influenza
    Mancuso, Carissa E.
    Gabay, Michael P.
    Steinke, Leah M.
    VanOsdol, Sherilyn J.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (7-8) : 1240 - 1249
12345